Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace
Author:
Affiliation:
1. Rega Institute for Medical Research; KU Leuven; Leuven Belgium
Publisher
Wiley
Subject
Infectious Diseases,Virology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/rmv.1842/fullpdf
Reference147 articles.
1. Benefit-risk assessment of new and emerging treatments for hepatitis C: focus on simeprevir and sofosbuvir;Gaetano;Drug Health Patient Saf,2014
2. The current state and future prospects of chronic hepatitis C virus infection treatment;Moore;Current Infectious Disease Reports,2014
3. Sofosbuvir in the current context of hepatitis C treatment;De Clercq;J Symptoms Signs,2014
4. Current race in the development of DAAs (direct-acting antivirals) against HCV;De Clercq;Biochemical Pharmacology,2014
5. Emerging therapies for the treatment of hepatitis C;Lange;EMBO Molecular Medicine,2014
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus;Current Medicinal Chemistry;2023-10-19
2. Recent Efforts in Identification of Privileged Scaffolds as Antiviral Agents;Chemistry & Biodiversity;2023-09-25
3. Virtual Screening of Telaprevir and Danoprevir Derivatives for Hepatitis C Virus NS3/4A Protease Inhibitors;Letters in Drug Design & Discovery;2022-12-07
4. Antivirales (a excepción del virus de la inmunodeficiencia humana y la hepatitis);EMC - Tratado de Medicina;2022-05
5. Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs;International Journal of Biological Macromolecules;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3